US Broker Ratings

HUTCHMED (China) Limited (HCM)

⚠️ No article content returned.

..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a 161.91% Potential Upside in the Biotech Arena

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing the attention of investors, offering a noteworthy potential upside of 161.91% based on its average analyst target price. With..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a Potential 51.49% Upside in Gene Editing

CRISPR Therapeutics AG (NASDAQ: CRSP) is at the forefront of the gene-editing revolution, providing investors with a unique opportunity to tap into groundbreaking advancements in biotechnology...

Warby Parker Inc. (WRBY) Stock Analysis: A Promising Player in the Healthcare Sector with Strong Analyst Support

Warby Parker Inc. (NYSE: WRBY), a prominent name in the healthcare sector specializing in medical instruments and supplies, has carved a niche in the eyewear market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a Promising 17% Upside Potential

DENTSPLY SIRONA Inc. (XRAY), a titan in the healthcare sector specializing in medical instruments and supplies, is managing a complex landscape of opportunities and challenges. With..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth with a 6.4% Revenue Surge in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare diagnostics and research industry, is capturing investor attention with its steady revenue growth and strategic..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a Promising Upside with CNS Innovations

Investors with a keen eye on the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect, particularly given its promising position within the..

Soleno Therapeutics, Inc. (SLNO): Investor Outlook on Potential 72.96% Upside in Biotech

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a burgeoning name in the biopharmaceutical sector, is attracting considerable attention from investors, especially given its compelling upside potential of 72.96%...

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Glimpse into Its Growth Potential Amidst Strong Buy Ratings

iRhythm Technologies, Inc. (NASDAQ: IRTC) is capturing attention within the healthcare sector, particularly in the medical device industry. Based in San Francisco, this digital healthcare company..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring an 85% Upside Potential and Robust Pipeline

For investors seeking exposure to the biopharmaceutical sector, Cytokinetics, Incorporated (NASDAQ: CYTK) presents an intriguing opportunity with its focus on developing groundbreaking muscle activators and inhibitors...

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Uncharted Waters with a $6.33 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based leader in the field of Traditional Chinese Medicine (TCM), has captured investor attention with its ambitious focus..

Grifols, S.A. (GRFS) Stock Analysis: Exploring the 20% Upside Potential for Investors

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, stands out as a key figure in the plasma therapeutic industry. Based in Barcelona, Spain,..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 1,353.80% Revenue Growth Surge

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector, showcasing an impressive trajectory that has piqued the interest of individual investors. The company,..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Pioneer with a 30.9% Revenue Growth Surge

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. Headquartered in Palo Alto,..

ADMA Biologics Inc (ADMA): Investor Outlook Highlights a Potential 63% Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing investor attention with its promising market position and potential upside. With a..

Bio-Rad Laboratories, Inc. (BIO): Investor Outlook with a 7.46% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $7.99 billion, this..

Verona Pharma plc (VRNA) Stock Analysis: Navigating the Biotech Wave with a Strong Market Cap

Verona Pharma plc (NASDAQ: VRNA) has emerged as a notable player in the biotechnology sector, capturing investor attention with its substantial market capitalization of $8.97 billion...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Evaluating a Promising 15.76% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing investor attention with its robust growth metrics and promising upside potential, as reflected in recent analyst ratings. Operating..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Discovering a 24.12% Potential Upside in a Resilient Healthcare Player

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent name in the over-the-counter (OTC) health and personal care products sector, is making waves with its diverse product..

Bruker Corporation (BRKR): Analyst Ratings and 31.48% Potential Upside Capture Investor Attention

Bruker Corporation (NASDAQ: BRKR), a stalwart in the healthcare sector specializing in medical devices, is making waves with its scientific instruments and diagnostic solutions. Based in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds